Viewing StudyNCT00248404



Ignite Creation Date: 2024-05-05 @ 12:07 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00248404
Status: COMPLETED
Last Update Posted: 2022-05-16
First Post: 2005-11-03

Brief Title: NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase TS
Sponsor: Kiadis Pharma
Organization: Kiadis Pharma

Conditions & Keywords Data

Conditions:
Name
Tumors
Keywords:
Name View
colorectal cancer View
ovarian cancer View
lung cancer View
breast cancer View
small bowel cancer View
Advanced recurrent or metastatic solid tumors of any type View
TS overexpression confirmed by fresh biopsy RTPCR View
Suitable for experimental monotherapy View